Pfizer might need to cut costs, as demand for Covid products falls

The following is from Reuters. Pfizer (PFE.N) on Tuesday [August 1] said it will launch a cost-cutting program if its Covid-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand. Pfizer said it anticipates more clarity on the future size of the Covid market later this year as infection rates rise […]